£ 500,000
( US $ 670,000)
Paul’ s estimate of the true cost of a single hiring decision
85 %
share of R & D Partners revenue from contract staffing at acquisition, the balance that motivated the 2022 deal
4 %
the division’ s year-onyear growth through the 2024 / 25 downturn
TWELVE
countries in the life sciences division’ s operating footprint
63 %
CFOs expecting greater M & A interest in 2026 than 2025
Source: Deloitte CFO Signals, Q4 2025
Paul Strouts CEO – Life Sciences Division
Acacium Group